Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

SELLAS Life Sciences Group Inc (RXK3.MU)

Compare
1.0470
+0.0545
+(5.49%)
At close: April 15 at 5:27:05 PM GMT+2
Loading Chart for RXK3.MU
  • Previous Close 0.9925
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 1.6520
  • Volume 0
  • Avg. Volume 3
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: RXK3.MU

View More

Performance Overview: RXK3.MU

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RXK3.MU
13.93%
S&P 500 (^GSPC)
8.25%

1-Year Return

RXK3.MU
16.11%
S&P 500 (^GSPC)
6.61%

3-Year Return

RXK3.MU
69.05%
S&P 500 (^GSPC)
22.86%

5-Year Return

RXK3.MU
84.14%
S&P 500 (^GSPC)
93.89%

Compare To: RXK3.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RXK3.MU

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    91.31M

  • Enterprise Value

    79.95M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    10.80

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RXK3.MU

View More

Company Insights: RXK3.MU

Research Reports: RXK3.MU

View More